Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding benefits and risks of the...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cochrane database of systematic reviews Ročník 5; s. CD013600
Hlavní autoři:	Piechotta, Vanessa, Iannizzi, Claire, Chai, Khai Li, Valk, Sarah J, Kimber, Catherine, Dorando, Elena, Monsef, Ina, Wood, Erica M, Lamikanra, Abigail A, Roberts, David J, McQuilten, Zoe, So-Osman, Cynthia, Estcourt, Lise J, Skoetz, Nicole
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 20.05.2021
Témata:	Bias Cause of Death COVID-19 - mortality COVID-19 - therapy COVID-19 Serotherapy Humans Immunization, Passive - adverse effects Immunization, Passive - methods Immunization, Passive - mortality Immunization, Passive - statistics & numerical data Non-Randomized Controlled Trials as Topic - statistics & numerical data Pandemics Randomized Controlled Trials as Topic - statistics & numerical data Respiration, Artificial - statistics & numerical data Treatment Outcome Ventilator Weaning - statistics & numerical data
ISSN:	1469-493X, 1469-493X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!